Fundraising Foxperiotherapia
Osaka, JP · 2 known investors
Find your way into periotherapia
Sign up to find every way you can get introduced to periotherapia
- Your email: who you already know at periotherapia, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the periotherapia team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Periotherapia develops antibody-based therapeutics targeting pathological periostin in the stromal environment to treat refractory diseases including cancer, diabetic retinopathy, and heart disease. The company, spun out from Osaka University, is conducting clinical trials for HER2-negative triple-negative breast cancer with support from Japan's AMED program.
Founders & leadership
YT
Yoshiaki TaniyamaDirector and Founder
ET
Eiji TaharaRepresentative Director, President, CEO and COO
Investors · 2
Frequently asked questions
- What does periotherapia do?
- Periotherapia develops antibody-based therapeutics targeting pathological periostin in the stromal environment to treat refractory diseases including cancer, diabetic retinopathy, and heart disease. The company, spun out from Osaka University, is conducting clinical trials for HER2-negative triple-negative breast cancer with support from Japan's AMED program.
- Who founded periotherapia?
- periotherapia was founded by Yoshiaki Taniyama.
- Who are periotherapia's investors?
- periotherapia's investors include Chishima Real Estate — Startup Investment, Eisai Innovation, Inc..
- Where is periotherapia headquartered?
- periotherapia is headquartered in Osaka, JP.